Leicester’s PHOSP-COVID study leading to development of new tests, new treatments, and improved outcomes for people living with long COVID and continues to inform the actions of policy-makers
The Post Hospitalisation Covid-19 study (PHOSP-COVID) is a national consortium led by experts in Leicester, working together to undertake research to better understand the symptoms and organ damage in people …
Assessing response to biologic injections in severe asthma to make sure we get the right drug to the right patient at the right time.
Asthma is one of the commonest chronic health conditions, affecting 1 in 15 people in the UK. Four out of 100 people with asthma have severe disease. Severe asthma is …
Revolutionary new treatment underpinned by research led by Leicester is transforming the lives of severe asthma sufferers.
Revolutionary new treatment underpinned by research led by Leicester is transforming thelives of severe asthma sufferers.Over 4 million people are prescribed asthma therapies in the UK, and it remains responsiblefor …